DLA Piper has advised Evli Growth Partners on its investment in Yazen Health

DLA Piper has advised Evli Growth Partners who led the oversubscribed EUR 19.5 million series A investment round in Yazen Health, with Helsana Healthinvest as co-lead. Yazen provides a digital service that combines GLP-1 medications with lifestyle advice.

The DLA Piper team mainly consisted of Gabriel Liska, Mikael Hagström, Josefine Mannerfelt, Thea Werr, Julia Engberg, Erik Brändt Öfverholm, Linnea Wernheim, Hanna Medelius and Malin Männikkö.

Read more here.